Ledger.Open graph →
SEC Form D · filed May 5, 2021

Maxona Pharmaceuticals, Inc

Offering
$10.0M
Sold
$5.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
KING OF PRUSSIA, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

David Nakamura · King of Prussia, PADirectorBehshad Sheldon · Baltimore, MDDirectorShahin Fatholahi · King of Prussia, PAExec · DirectorDavid Nakamura · King of Prussia, PADirectorBehshad Sheldon · Baltimore, MDDirectorShahin Fatholahi · King of Prussia, PAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗